Works matching IS 11727047 AND DT 2025 AND VI 39 AND IP 7

Results: 8

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 693, doi. 10.1007/s40263-025-01191-7

By:

Novi, Giovanni;
Bovis, Francesca;
Sciolla, Chiara;
Frau, Jessica;
Minetti, Matteo;
Napoli, Francesca;
Vianello, Marika;
Greco, Giacomo;
Sechi, Elia;
Bellomo, Andrea;
Garelli, Paola;
Spiezia, Antonio Luca;
Fantozzi, Roberta;
Schirò, Giuseppe;
Ghezzi, Laura;
Zecca, Chiara;
Signoriello, Elisabetta;
Brambilla, Laura;
Lucchini, Matteo;
Bonavita, Simona

Publication type:

Article

Efficacy and Safety of Escitalopram Combined with Tandospirone Citrate in Treating Patients with Vascular Depression and Chronic Insomnia: A Randomized Controlled Trial.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 669, doi. 10.1007/s40263-025-01190-8

By:

Chen, Hongbin;
Zeng, Guiying;
Wu, Shufang;
Xie, Sengpei;
Chen, Xinyan;
Wu, Weiwei;
Chen, Hui;
Chen, Ronghua;
Xiao, Yingchun

Publication type:

Article

Optimal Dose of Baclofen for the Treatment of Alcohol Use Disorder: A Systematic Review and Dose-Response Meta-analysis.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 651, doi. 10.1007/s40263-025-01188-2

By:

Kotake, Kazumasa;
So, Ryuhei;
Hashimoto, Nozomu;
Imai, Eriya;
Kaneko, Takao;
Banno, Masahiro;
Furukawa, Yuki

Publication type:

Article

Correction: The Evolution of Anti‑CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function.

Published in:

2025

By:

Cree, Bruce A. C.;
Berger, Joseph R.;
Greenberg, Benjamin

Publication type:

Correction Notice

Pharmacological Frontiers: The Rise of Selective Na<sub>V</sub>1.8 Inhibition for Pain Management.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 633, doi. 10.1007/s40263-025-01186-4

By:

Eid, Ali H.

Publication type:

Article

Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 637, doi. 10.1007/s40263-025-01185-5

By:

Lee, Seungjoo;
Kim, Moinay;
Kwon, Sae Min;
Kwon, Min-Yong;
Kim, Chang-Hyun;
Son, Nak-Hoon;
Kim, Jae Hyun

Publication type:

Article

Effect of Naltrexone on Spinal and Supraspinal Pain Mechanisms and Functional Capacity in Women with Fibromyalgia: Exploratory Outcomes from the Randomized Placebo-Controlled FINAL Trial.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 685, doi. 10.1007/s40263-025-01183-7

By:

Bruun, Karin Due;
Christensen, Robin;
Amris, Kirstine;
Blichfeldt-Eckhardt, Morten Rune;
Bye-Møller, Lars;
Henriksen, Marius;
Alkjaer, Tine;
Toft, Palle;
Holsgaard-Larsen, Anders;
Vaegter, Henrik Bjarke

Publication type:

Article

Cenobamate: A Review in Focal-Onset Seizures.

Published in:

CNS Drugs, 2025, v. 39, n. 7, p. 707, doi. 10.1007/s40263-025-01178-4

By:

Nie, Tina;
Hoy, Sheridan M.

Publication type:

Article